| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10129536 | American Heart Journal | 2018 | 22 Pages |
Abstract
The EVOLVE Short DAPT study will prospectively define the safety of DAPT discontinuation at 3 months in high bleeding risk patients treated with the SYNERGY stent.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Laura MD, MSc, Ajay J. MD, SM, Stephan MD, Robert W. MD, MSc, Harold L. MD, Matthew J. MD, Thomas MD, PhD, Dominic J. MD, Ian T. AM, Dean J. MD,